Copyright Reports & Markets. All rights reserved.

Global Oligonucleotide Synthesis Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Synthesized Oligonucleotides
      • 1.4.3 Reagents
      • 1.4.4 Equipment
    • 1.5 Market by Application
      • 1.5.1 Global Oligonucleotide Synthesis Market Share by Application (2014-2025)
      • 1.5.2 PCR
      • 1.5.3 DNA
      • 1.5.4 RNAi
      • 1.5.5 Research
      • 1.5.6 Therapeutic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Oligonucleotide Synthesis Market Size
    • 2.2 Oligonucleotide Synthesis Growth Trends by Regions
      • 2.2.1 Oligonucleotide Synthesis Market Size by Regions (2014-2025)
      • 2.2.2 Oligonucleotide Synthesis Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Oligonucleotide Synthesis Market Size by Manufacturers
      • 3.1.1 Global Oligonucleotide Synthesis Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oligonucleotide Synthesis Key Players Head office and Area Served
    • 3.3 Key Players Oligonucleotide Synthesis Product/Solution/Service
    • 3.4 Date of Enter into Oligonucleotide Synthesis Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Oligonucleotide Synthesis Market Size by Type (2014-2019)
    • 4.2 Global Oligonucleotide Synthesis Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Oligonucleotide Synthesis Market Size (2014-2019)
    • 5.2 Oligonucleotide Synthesis Key Players in United States
    • 5.3 United States Oligonucleotide Synthesis Market Size by Type
    • 5.4 United States Oligonucleotide Synthesis Market Size by Application

    6 Europe

    • 6.1 Europe Oligonucleotide Synthesis Market Size (2014-2019)
    • 6.2 Oligonucleotide Synthesis Key Players in Europe
    • 6.3 Europe Oligonucleotide Synthesis Market Size by Type
    • 6.4 Europe Oligonucleotide Synthesis Market Size by Application

    7 China

    • 7.1 China Oligonucleotide Synthesis Market Size (2014-2019)
    • 7.2 Oligonucleotide Synthesis Key Players in China
    • 7.3 China Oligonucleotide Synthesis Market Size by Type
    • 7.4 China Oligonucleotide Synthesis Market Size by Application

    8 Japan

    • 8.1 Japan Oligonucleotide Synthesis Market Size (2014-2019)
    • 8.2 Oligonucleotide Synthesis Key Players in Japan
    • 8.3 Japan Oligonucleotide Synthesis Market Size by Type
    • 8.4 Japan Oligonucleotide Synthesis Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Oligonucleotide Synthesis Market Size (2014-2019)
    • 9.2 Oligonucleotide Synthesis Key Players in Southeast Asia
    • 9.3 Southeast Asia Oligonucleotide Synthesis Market Size by Type
    • 9.4 Southeast Asia Oligonucleotide Synthesis Market Size by Application

    10 India

    • 10.1 India Oligonucleotide Synthesis Market Size (2014-2019)
    • 10.2 Oligonucleotide Synthesis Key Players in India
    • 10.3 India Oligonucleotide Synthesis Market Size by Type
    • 10.4 India Oligonucleotide Synthesis Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Oligonucleotide Synthesis Market Size (2014-2019)
    • 11.2 Oligonucleotide Synthesis Key Players in Central & South America
    • 11.3 Central & South America Oligonucleotide Synthesis Market Size by Type
    • 11.4 Central & South America Oligonucleotide Synthesis Market Size by Application

    12 International Players Profiles

    • 12.1 Integrated DNA Technologies
      • 12.1.1 Integrated DNA Technologies Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Oligonucleotide Synthesis Introduction
      • 12.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.1.5 Integrated DNA Technologies Recent Development
    • 12.2 Merck KGaA
      • 12.2.1 Merck KGaA Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Oligonucleotide Synthesis Introduction
      • 12.2.4 Merck KGaA Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.2.5 Merck KGaA Recent Development
    • 12.3 Eurofins Genomics
      • 12.3.1 Eurofins Genomics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Oligonucleotide Synthesis Introduction
      • 12.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.3.5 Eurofins Genomics Recent Development
    • 12.4 Thermo Fisher Scientific
      • 12.4.1 Thermo Fisher Scientific Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Oligonucleotide Synthesis Introduction
      • 12.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.4.5 Thermo Fisher Scientific Recent Development
    • 12.5 Bioautomation
      • 12.5.1 Bioautomation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Oligonucleotide Synthesis Introduction
      • 12.5.4 Bioautomation Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.5.5 Bioautomation Recent Development
    • 12.6 Agilent Technologies
      • 12.6.1 Agilent Technologies Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Oligonucleotide Synthesis Introduction
      • 12.6.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.6.5 Agilent Technologies Recent Development
    • 12.7 Eurogentec
      • 12.7.1 Eurogentec Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Oligonucleotide Synthesis Introduction
      • 12.7.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.7.5 Eurogentec Recent Development
    • 12.8 GE Healthcare
      • 12.8.1 GE Healthcare Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Oligonucleotide Synthesis Introduction
      • 12.8.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.8.5 GE Healthcare Recent Development
    • 12.9 LGC Biosearch Technologies
      • 12.9.1 LGC Biosearch Technologies Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Oligonucleotide Synthesis Introduction
      • 12.9.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.9.5 LGC Biosearch Technologies Recent Development
    • 12.10 Nitto Denko Avecia
      • 12.10.1 Nitto Denko Avecia Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Oligonucleotide Synthesis Introduction
      • 12.10.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2014-2019)
      • 12.10.5 Nitto Denko Avecia Recent Development
    • 12.11 Genscript
    • 12.12 Genedesign
    • 12.13 TriLink Biotechnologies
    • 12.14 Bio-Synthesis
    • 12.15 ATDBio

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
      Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
      In 2018, the global Oligonucleotide Synthesis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Oligonucleotide Synthesis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Synthesis development in United States, Europe and China.

      The key players covered in this study
      Integrated DNA Technologies
      Merck KGaA
      Eurofins Genomics
      Thermo Fisher Scientific
      Bioautomation
      Agilent Technologies
      Eurogentec
      GE Healthcare
      LGC Biosearch Technologies
      Nitto Denko Avecia
      Genscript
      Genedesign
      TriLink Biotechnologies
      Bio-Synthesis
      ATDBio

      Market segment by Type, the product can be split into
      Synthesized Oligonucleotides
      Reagents
      Equipment

      Market segment by Application, split into
      PCR
      DNA
      RNAi
      Research
      Therapeutic

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oligonucleotide Synthesis status, future forecast, growth opportunity, key market and key players.
      To present the Oligonucleotide Synthesis development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Oligonucleotide Synthesis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now